Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TGTX | COMMON STOCK | Award | $0 | +25K | +3.98% | $0.00 | 653K | Jun 18, 2021 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Reflects a grant of restricted shares relating that will vest in according to the following schedule: 50% on January 1, 2022, and 25% on each of January 1, 2023 and 2024. |
F2 | Includes shares of restricted Common Stock, which are subject to vesting and 107,500 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing. |